United States Pharmaceutical Excipients Market expected to grow at a CAGR of 5.5% during 2024-2031 | Top Companies - DuPont de Nemours Inc, Roquette Feres, Ashland Global Holdings Inc

"Pharmaceutical Excipients Market is forecasted to reach at a CAGR of 5.5 % during the forecast period (2024-2031)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/pharmaceutical-excipients-market?sp

United States: Recent Industry Developments

✅ In November 2025, Ashland Inc. expanded its pharmaceutical excipient portfolio by introducing a new line of cellulose‐based polymers tailored for injectable and biologic formulations. The product suite supports high‐dose tablets, coatings and complex dosage forms. It marks Ashland's push into advanced excipient functionalities for next‐generation drugs.

✅ In October 2025, Roquette completed the integration of IFF Pharma Solutions, enhancing its excipient capabilities in multifunctional binder‐disintegrant systems and sustainable supply chains. The merger strengthens Roquette's position in global excipient manufacturing and provides formulators with broader material choices. It highlights consolidation and value‐chain optimisation in the excipient sector.

✅ In September 2025, market data reported that the global pharmaceutical excipients market reached approximately USD 10.8 billion in 2025 and is expected to hit around USD 14.9 billion by 2030, driven by rising demand for generic drugs, novel delivery systems and specialty excipients. The growth emphasises how excipients, though "inactive", are increasingly strategic in drug formulation and patient‐centric development. It signals opportunity for excipient suppliers and formulators alike.

Japan: Recent Industry Developments

✅ In November 2025, Asahi Kasei Finechem launched its CEOLUSTM high‐functional microcrystalline cellulose grades designed for high‐dose, small‐tablet and low‐compactibility formulations in Japan. The new excipients enhance tablet integrity, flowability and manufacturability in advanced oral solid dosage products. They reflect Japan's focus on precision formulation for emerging drug formats.

✅ In October 2025, at CPhI Japan 2025, IFF Pharma Solutions (Asia‐Pacific operations) showcased its "low‐nitrite" excipient portfolio including Avicel PH LN and Low Nitrite METHOCELTM to help mitigate nitrosamine risk in oral solid dosage. The products respond to Japan's stringent regulatory scrutiny on nitrosamines and excipient safety. They underscore how excipients are now subject to advanced safety and compliance demands.

✅ In September 2025, regulatory commentary highlighted that the Japanese market is accelerating adoption of novel excipients for controlled‐release and orally disintegrating tablet (ODT) applications to address ageing population and swallowing‐difficulty issues. The shift is accompanied by formulators seeking excipients with enhanced disintegration, matrix control and patient‐friendly formats. It shows Japan moving towards higher functional excipient demand rather than basic filler/binder roles.

Pharmaceutical Excipients Market: Drivers

The pharmaceutical excipients market is experiencing strong growth as the demand for high-quality, safe, and effective drug formulations continues to rise globally. Excipients substances other than the active pharmaceutical ingredient (API)-play a crucial role in improving drug stability, bioavailability, solubility, and patient compliance. Increasing pharmaceutical manufacturing, the expansion of generic drugs, and the rise of biologics and novel drug delivery systems are driving market adoption. Additionally, growing regulatory emphasis on excipient quality, safety, and functionality is pushing manufacturers to invest in advanced, well-characterized excipient products. The shift toward patient-centric formulations, including orally disintegrating tablets, controlled-release systems, and parenteral preparations, further boosts demand.

Technological advancements in excipient design, such as multifunctional polymers, solubilizers, and coating agents, are enabling improved drug performance and therapeutic efficacy. The growing trend of personalized medicine and the development of complex formulations are creating opportunities for specialized and high-value excipients. Increasing use of natural, biodegradable, and non-toxic excipients is also aligning with sustainability and regulatory compliance goals. Moreover, expansion of pharmaceutical R&D in emerging markets, coupled with rising healthcare expenditure, is fueling market growth. With ongoing innovation in drug delivery technologies and a focus on quality, the pharmaceutical excipients market is poised for sustained and technology-driven expansion in the coming years.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pharmaceutical-excipients-market?sp

Pharmaceutical Excipients Market: Major Players

DuPont de Nemours Inc, Roquette Feres, Ashland Global Holdings Inc, BASF SE, Evonik Industries AG, Associated British Foods plc, Archer Daniels Midland Company, Lubrizol Corporation, Croda International and Innophos Holdings.

Segment Covered in the Pharmaceutical Excipients Market:

By Product
The market is segmented into Organic, Inorganic, and Other excipients. Organic excipients hold a significant share owing to their biocompatibility, stability, and suitability for a wide range of formulations. Inorganic excipients are primarily used for their binding, bulking, and coating properties, especially in solid dosage forms. The other category includes specialty and novel excipients designed to enhance drug solubility and bioavailability.

By Functionality
Based on functionality, the market is classified into Fillers, Diluents, Coatings, Disintegrants, and Others. Fillers and diluents account for a major portion due to their extensive use in tablet and capsule formulations. Coatings are gaining demand for controlled and sustained-release formulations, while disintegrants are essential for improving drug dissolution rates.

By Formulation
The market is further divided by formulation type into Oral, Parenteral, Topical, and Others. Oral formulations dominate the segment, attributed to ease of administration and patient compliance. Parenteral formulations are witnessing steady growth due to the increasing use of injectable biologics, whereas topical formulations are driven by expanding dermatology and pain management applications.

Research Process:

Both primary and secondary data sources have been used in the Pharmaceutical Excipients Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Pharmaceutical Excipients Market Research Industry:

➠ Who leads the Pharmaceutical Excipients industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Pharmaceutical Excipients market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Pharmaceutical Excipients market growth?
➠ What are the dominant sales and distribution strategies in the Pharmaceutical Excipients industry?

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-excipients-market
(Purchase 2 or more Repots and get 50% Discount)

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.